Anika Therapeutics Inc.

This committee controls taxation, trade, and entitlement spending (like Medicare). Decisions on corporate tax policy and Medicare reimbursement rates for procedures using Anika's devices directly affect its profitability and revenue streams.

This committee directly allocates federal discretionary spending. Its decisions on funding for agencies like the VA, NIH, and healthcare programs (e.g., Medicare/Medicaid) directly impact demand and reimbursement for Anika's products.

This committee has direct oversight of the FDA, which regulates medical devices, and the NIH, which funds medical research. Its decisions on labor laws also impact manufacturing costs, making it highly influential for Anika.

This committee's oversight of intellectual property (patents) and antitrust laws is highly relevant. Medical device companies rely heavily on patent protection, and antitrust scrutiny can impact M&A activity in the sector.

This committee oversees the Department of Veterans Affairs (VA), whose funding decisions directly impact government healthcare contractors and medical device manufacturers like Anika, which could supply VA hospitals.